Tension-type headaches: What they are and how to treat them

Primary Care - Clinics in Office Practice

Volumn 31, Issue 2, 2004, Pages 293-311

  Krusz, John Claude ^a  

^a Anodyne PainCare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BOTULINUM TOXIN; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; CLONIDINE; DESIPRAMINE; ETIRACETAM; FLUOXETINE; GABAPENTIN; GABATRIL; IBUPROFEN; LAMOTRIGINE; METHADONE; NEFAZODONE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PARACETAMOL; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TIZANIDINE; TOPIRAMATE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; ZALEPLON; ZOLPIDEM TARTRATE; ZONISAMIDE;

ACUPUNCTURE; ANXIETY DISORDER; BIOCHEMISTRY; BIPOLAR DISORDER; BODY WEIGHT DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DEPRESSION; DROWSINESS; DRUG EFFECT; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RELEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HYPNOSIS; LOCUS CERULEUS; MOOD DISORDER; MUSCLE SPASM; NEUROMODULATION; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; TENSION HEADACHE; VISUAL ANALOG SCALE; XEROSTOMIA;

ANALGESICS; ANALGESICS, OPIOID; BIOFEEDBACK (PSYCHOLOGY); BOTULINUM TOXINS; CHRONIC DISEASE; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROTRANSMITTER AGENTS; PRACTICE GUIDELINES; PSYCHOTHERAPY; RISK FACTORS; TENSION-TYPE HEADACHE; UNITED STATES;

EID: 2542451725     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2004.02.004     Document Type: Review

References (75)

1. Ziegler D.K., Hassanein R.S. Specific headache phenomena: their frequency and coincidence. Headache. 30:1990;152-156
2. Olesen J. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 8:(Supp 7):1988;1-96
3. Spira P.J. Tension headache. Aust Fam Physician. 27:1998;597-600
4. Marks D.R., Rapoport A.M. Practical evaluation and diagnosis of headache. Semin Neurol. 17:1997;307-312
5. Friedman A.P., Finley K.M., Graham J.R., Kunkle E.C., Ostfeld A.M., Wolff H.G. Classification of headache. The Ad Hoc Committee on the Classification of Headache. JAMA. 179:1962;717-718
6. Lipton R.B., Stewart W.F., Cady R., Hall C., O'Quinn S., Kuhn T., et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 40:2000;783-791
7. Marcus D.A. Migraine and tension-type headaches: the questionable validity of current classification systems. Clin J Pain. 8:1992;28-36
8. de Bruijn-Kofman A.T., van de Wiel H., Sorbi M.J. Classification of headache on the basis of the HIS Diagnostic Criteria. Headache Quarterly. 10:1999;45-49
9. Lebbink J., Spierings E.L., Messinger H.B. A questionnaire survey of muscular symptoms in chronic headache: an age- and sex-controlled study. Clin J Pain. 7:1991;95-101
10. Sutton E.P., Belar C.D. Tension headache patients versus controls: a study of EMG parameters. Headache. 22:1982;133-136
11. Bakal D.A., Kaganov J.A. Muscle contraction and migraine headache: psychophysiologic comparison. Headache. 17:1977;208-215
12. Ashina M., Bendtsen L., Jensen R., Sakai F., Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain. 79:1999;201-205
13. Riley T.L. Muscle-contraction headache. Neurol Clin. 1983;489-500
14. Ashina M., Bendtsen L., Jensen R., Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain. 123:2000;1830-1837
15. Ashina M., Lassen L.H., Bendtsen L., Jensen R., Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet. 353:1999;287-289
16. Gotoh F., Komatsumoto S., Araki N., Gomi S. Noradrenergic nervous activity in migraine. Arch Neurol. 41:1984;951-955
17. Mikamo K., Takeshima T., Takahashi K. Cardiovascular sympathetic hypofunction in muscle contraction headache and migraine. Headache. 29:1989;86-89
18. Takeshima T., Takao Y., Urakami K., Nishikawa S., Takahashi K. Muscle contraction headache and migraine: platelet activation and plasma norepinephrine during the cold pressor test. Cephalalgia. 9:1989;7-13
19. Araki N. Autonomic nervous activity in migraine. Rinsho Shinkeigaku. 35:1995;1336-1338
20. Castillo J., Martinez F., Leira R., Lema M., Noya M. Plasma monoamines in tension-type headache. Headache. 34:1994;531-535
21. Anthony M. Biochemical indices of sympathetic activity in migraine. Cephalalgia. 1:1981;83-89
22. Krusz J.C., Belanger J., Mills C. Tizanidine: a novel effective agent for the treatment of chronic headaches. Headache Quarterly. 11:2000;41-45
23. Shimomura T. Tension-type headache: 5-hydroxytryptamine and related substances. Rinsho Shinkeigaku. 35:1995;1342-1344
24. Srikiatkhachorn A., Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 16:1996;423-426
25. Raskin N.H. Headache. 2nd edition :1988;Churchill Livingston, New York
26. Rapoport A., Stang P., Gutterman D.L., Cady R., Markley H., Weeks R., et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 36:1996;14-19
27. Forward S.P., McGrath P.J., MacKinnon D., Brown T.L., Swann J., Currie E.L. Medication patterns of recurrent headache sufferers: a community study. Cephalagia. 18:1998;146-151
28. Wagstaff A.J., Bryson H.M. Tizanidine: a review of its pharmacology, clinical effects and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs. 53:1997;435-452
29. Fogelholm R, Murros K. Tizanidine in chronic teansion-type headache: a placebo-controlled, double-blind cross-over study. Headache 32:509-13.
30. Murros K., Kataja M., Hedman C., Havanka H., Sako E., Farkkila M., et al. Mofified-release formulation of tizanidine in chronic tension-type headache. Headache. 40:2000;633-637
31. Saper J.R., Lake A.E. III, Cantrell D.Y., Winner P.K., White J.R. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter-outcome study. Headache. 42:2002;470-482
32. Cerbo R., Barbanti P., Fabbrini G., Pascali M.P., Catarci T. Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache. 38:1998;453-457
33. Bendtsen L., Jensen R., Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 61:1996;285-290
34. Cohen G.L. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache. 37:1997;433-436
35. Langemark M., Olesen J. Sulpride and paroxitine in the treatment of chronic tension-type headache. Headache. 34:1994;20-24
36. Saper J.R., Silberstein S.D., Lake A.E. III, Winters M.E. Double-blind trial of fluoxetine: chronic daily headache and migraine headache. Headache. 34:1994;497-502
37. Walker Z., Walker R.W.H., Robertson M.M., Stansfield S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache. 38:1998;523-528
38. Adelman L.C., Adelman J.U., Von Seggern R., Mannix L.K. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache. 40:2000;572-580
39. Mitsikostas D.D., Gatzonis S., Thomas A., Ilias A. Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand. 96:1997;247-251
40. Cutrer F.M. Pain-sensitive cranial structures: chemical anatomy. Silberstein S.D., Lipton R.B., Dalessio D.J. Wolff's headache and other head pain. 7th edition :2001;50-56 Oxford University Press, New York
41. Goadsby P.J. Pathophysiology of headache. Silberstein S.D., Lipton R.B., Dalessio D.J. Wolff's headache and other head pain. 7th edition :2001;57-72 Oxford University Press, New York
42. Cady R.K., Lipton R.B., Hall C., Stewart W.F., O'Quinn S., Gutterman D. Treatment of mild migraine in disabled migraine sufferers: results of the Spectrum Study. Headache. 40:2000;792-797
43. Burstein R., Yarnitsky D., Goor-Aryeh I., Ransil B.J., Bajwa Z.H. An association between migraine and cutaneous allodynia. Ann Neurol. 47:2000;614-624
44. Burstein R., Cutrer M.F., Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 123:2000;1703-1709
45. Krusz J.C. Intravenous valproate sodium in the treatment of migraine headaches in the headache clinic. Headache Quarterly. 12:2001;39-41
46. Robbins L.R. Intravenous sodium valproate injection for prolonged migraine headache. American Journal of Pain Management. 11:2001;5-7
47. Karpitsky V.V., Schwartz T.H., Gurnett C.A., Pentella K.J., Sohn R.U. Intravenous valproate in the treatment of chronic daily headache. Cephalalgia. 21:2001;479
48. Mathew N.T., Rapoport A., Saper J., Magnus L., Klapper J., Ramadan N., et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 41:2001;119-128
49. Wheeler S.D. Lamotrigine efficacy in migraine prevention. Cephalagia. 21:2001;374
50. Lampl C., Buzath A., Klinger D., Neumann K. Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia. 19:1999;58-63
51. D'Andrea G., Granella F., Cadaldini M., Manzoni G.C. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia. 19:1999;64-66
52. Krusz JC. Lamotrigine as prophylaxis therapy for refractory migraine. Abstract presented at the meeting of the American Headache Society, Seattle, Washington, 2002.
53. Krusz J.C., Scott V. Topiramate in the treatment of chronic migraine and other headaches. [abstract] Headache. 39:1999;363
54. Storey J.T., Calder C.S., Potter D.L. Potential role of topiramate (TPM) in the treatment of intractable daily headache: a retrospective pilot study. Neurology. 52:(Suppl 1):1999;A211
55. Krusz J.C., Belanger J., Scott V.B. Tiagabine in the treatment of very refractory migraines and other headaches. Headache. 39:1999;363
56. ™) as prophylaxis for refractory migraines. [abstract] International Migraine Trust. 20:2000;425
57. ™) as prophylaxis for resistant headaches, (poster abstract presented at: Headache update 2000, Lake Buena Vista, Florida) in: Headache Quarterly 2000;12:54.
58. Krusz J.C. Levetiracetam as prophylaxis for resistant headaches. Cephalalgia. 21:2001;373
59. Krusz J.C. Levetiracetam (Keppra): novel agent for refractory chronic neuropathic pain. J Neurol Sci. 187:2001;S474
60. Krusz J.C. Intravenous levetiracetam. [abstract] International Migraine Trust. 22:2002;604
61. Krusz J.C. Zonisamide in the treatment of headache and pain disorders. J Neurol Sci. 187:2001;S107
62. Smith TR. Treatment of refractory chronic daily headache with zonisamide: a case series. Presented at the meeting of the 10th American Headache Society Meeting, New York, 2001.
63. Saper J.R., Rothrock J.F., Rome J.D., Dodick D. Roundtable discussion: The role of opioid therapy in managing chronic daily headache. Johns Hopkins Advanced Studies in Medicine. 2:2002;762-766
64. Robbins L. Long-acting opioids for severe chronic daily headache. Headache Quarterly. 10:(3):1999;135-139
65. Rollnik J.D., Karst M., Fink M., Dengler R. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Headache. 41:2001;985-989
66. Schmitt W.R., Slowery E., Fravil N., Weber S., Burgender J-M. Effect of botulinum toxin a injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 41:2001;658-664
67. Krusz JC. Intradermal botulinum toxin, type B, for cervicogenic migraine (poster presented at 10th World Congress on Pain, San Diego, California, August, 2002). In: Abstracts: 201, IASP Press, August 2002.
68. Krusz J.C. Botulinum toxin, type A given intradermally for cervicogenic migraine (poster presented at the 14th Migraine Trust International Symposium, London, UK, September, 2002). Cephalagia. 22:2002;607
69. Holroyd K.A., O'Donnell F.J., Stensland M. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA. 285:2001;2208-2215
70. Hammill J.M., Cook T.M., Rosecrance J.C. Effectiveness of a physical therapy regimen in the treatment of tension type headache. Headache. 36:1996;149-153
71. Blanchard E.B., Andrasik F., Evans D., Neff D., Appelbaum K.A., Rodidnok L.D. Behavioral treatment of 250 chronic headache patients: a clinical replication series. Behav Ther. 16:1985;308-327
72. Blanchard E.B., Appelbaum K.A., Guarnieri P., Morrill B., Dentinger M.P. Five year prospective follow-up on the treatment of chronic headache with biofeedback and/or relaxation. Headache. 27:1987;580-583
73. Attanasio V., Andrasik F., Blanchard E.B. Cognitive therapy and relaxation training muscle contraction headache: efficacy in and cost-effectiveness. Headache. 27:1987;254-257
74. Melchart D., Linde K., Fischer P., White A., Allais G., Vickers A., et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalagia. 19:1999;779-786
75. Boline P.D., Kassak K., Bronfort G., Nelson C., Anderson A.V. Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. J Manipulative Physiol Ther. 18:1995;148-154